Clinical Trials Directory

Trials / Completed

CompletedNCT04710173

Establishment of a Early Risk Model of ECMO in Children With ARDS

Establishment of a Early Risk Model of Extracorporeal Membrane Oxygenation(ECMO) in Children With Acute Respiratory Distress Syndrome (ARDS) in China

Status
Completed
Phase
Study type
Observational
Enrollment
95 (actual)
Sponsor
Children's Hospital of Fudan University · Academic / Other
Sex
All
Age
28 Days – 18 Years
Healthy volunteers
Not accepted

Summary

The key problem in the treatment of ARDS is refractory hypoxemia. Extracorporeal Membrane Oxygenation (ECMO) is an extracorporeal oxygenation of venous blood to eliminate carbon dioxide and return to the body. It has been an important part of the rescue treatment for ARDS. This study intends to explore the timing of ECMO. The main research hypothesis is that the appropriate timing of ECMO treatment can improve the weaning success rate and survival rate of children with severe ARDS; it is expected to provide a basis for determining the best timing of ECMO treatment

Detailed description

Severe acute respiratory distress syndrome (ARDS), especially those caused by severe viral pneumonia, is still an important factor in the death of children, with a case fatality rate of 55%. The treatment includes lung protective ventilation and advanced ventilation support, but the effect is still not ideal for severe patients. ECMO can effectively support the respiratory system and provide good oxygen exchange. However, the survival rate of ECMO treatment in children with ARDS has a large bias.One of the key factors is the uneven timing of ECMO activation, which significantly affects the prognosis.This study intends to design a multi-center, prospective, non-randomized controlled trial , through retrospective research to find relevant factors affecting the prognosis of ECMO treatment, and to screen key indicators related to the timing of intervention; through a prospective cohort study to screen Good indicators and cut-off values suitable for starting ECMO , constructing and verifying comprehensive prediction models.

Conditions

Interventions

TypeNameDescription
PROCEDUREECMOVV-ECMO

Timeline

Start date
2018-01-01
Primary completion
2022-12-30
Completion
2022-12-30
First posted
2021-01-14
Last updated
2024-02-07

Locations

3 sites across 1 country: China

Source: ClinicalTrials.gov record NCT04710173. Inclusion in this directory is not an endorsement.